124 related articles for article (PubMed ID: 24727895)
21. Mitochondria-targeted metformin (mitomet) inhibits lung cancer in cellular models and in mice by enhancing the generation of reactive oxygen species.
Shameem M; Bagherpoor AJ; Nakhi A; Dosa P; Georg G; Kassie F
Mol Carcinog; 2023 Nov; 62(11):1619-1629. PubMed ID: 37401866
[TBL] [Abstract][Full Text] [Related]
22. Bazedoxifene Suppresses the Growth of Osteosarcoma Cells by Inhibiting IL-6 and IL-11/GP130 Signaling Pathway.
Wu X; Cao Y; Xiao H; Feng J; Lin J
J Pediatr Hematol Oncol; 2024 Jan; 46(1):8-14. PubMed ID: 37962127
[TBL] [Abstract][Full Text] [Related]
23. Targeting CD36 determines nicotine derivative NNK-induced lung adenocarcinoma carcinogenesis.
Li MY; Wang M; Dong M; Wu Z; Zhang R; Wang B; Huang Y; Zhang X; Zhou J; Yi J; Chen GG; Liu LZ
iScience; 2023 Aug; 26(8):107477. PubMed ID: 37599821
[TBL] [Abstract][Full Text] [Related]
24. Long Noncoding RNA PSMB8-AS1 Mediates the Tobacco-Carcinogen-Induced Transformation of a Human Bronchial Epithelial Cell Line by Regulating Cell Cycle.
Ou WT; Wan QX; Wu YB; Sun X; Li YL; Tang D; Zhang J; Li SS; Wang NY; Liu ZL; Wu JJ
Chem Res Toxicol; 2024 May; ():. PubMed ID: 38771128
[TBL] [Abstract][Full Text] [Related]
25. gp130 cytokines are positive signals triggering changes in gene expression and axon outgrowth in peripheral neurons following injury.
Zigmond RE
Front Mol Neurosci; 2011; 4():62. PubMed ID: 22319466
[TBL] [Abstract][Full Text] [Related]
26. Cytokines and their receptors in cardiovascular diseases--role of gp130 signalling pathway in cardiac myocyte growth and maintenance.
Yamauchi-Takihara K; Kishimoto T
Int J Exp Pathol; 2000 Feb; 81(1):1-16. PubMed ID: 10718860
[TBL] [Abstract][Full Text] [Related]
27. E3 Ubiquitin Ligase NEDD4L Negatively Regulates Skin Tumorigenesis by Inhibiting IL-6/GP130 Signaling Pathway.
Liu H; Wang N; Yang R; Luan J; Cao M; Zhai C; Wang S; Wei M; Wang D; Qiao J; Liu Y; She W; Guo N; Liao B; Gou X
J Invest Dermatol; 2024 Apr; ():. PubMed ID: 38580105
[TBL] [Abstract][Full Text] [Related]
28. Physical binding of the tobacco smoke carcinogen NNK diazonium ion to the human tumor suppressor gene TP53 Exon 5.
Deligkaris C; Millam E
Toxicol Res (Camb); 2019 Jul; 8(4):531-543. PubMed ID: 31367336
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of a signaling modality within the gp130 receptor enhances tissue regeneration and mitigates osteoarthritis.
Shkhyan R; Flynn C; Lamoure E; Sarkar A; Van Handel B; Li J; York J; Banks N; Van der Horst R; Liu NQ; Lee S; Bajaj P; Vadivel K; Harn HI; Tassey J; Lozito T; Lieberman JR; Chuong CM; Hurtig MS; Evseenko D
Sci Transl Med; 2023 Mar; 15(688):eabq2395. PubMed ID: 36947594
[TBL] [Abstract][Full Text] [Related]
30. STAT3-driven hematopoiesis and lymphopoiesis abnormalities are dependent on serine phosphorylation.
Balic JJ; White CL; Dawson R; Gough D; McCormack MP; Jenkins BJ
Cytokine; 2020 Mar; 130():155059. PubMed ID: 32200265
[TBL] [Abstract][Full Text] [Related]
31. Design, Synthesis of (±)-Millpuline A, and Biological Evaluation for the Lung Cell Protective Effects through SRC.
Zhang H; Guo X; Zhou D; Wen J; Tang Y; Wang J; Liu Y; Chen G; Li N
ChemMedChem; 2023 Oct; 18(20):e202300219. PubMed ID: 37704587
[TBL] [Abstract][Full Text] [Related]
32. Dissecting the Puzzling Roles of FAM46C: A Multifaceted Pan-Cancer Tumour Suppressor with Increasing Clinical Relevance.
Lai G; De Grossi F; Catusi I; Pesce E; Manfrini N
Cancers (Basel); 2024 Apr; 16(9):. PubMed ID: 38730656
[TBL] [Abstract][Full Text] [Related]
33. The IL6-like Cytokine Family: Role and Biomarker Potential in Breast Cancer.
Martínez-Pérez C; Kay C; Meehan J; Gray M; Dixon JM; Turnbull AK
J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834425
[TBL] [Abstract][Full Text] [Related]
34. Retraction Note: IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer.
Guo J; Kim D; Gao J; Kurtyka C; Chen H; Yu C; Wu D; Mittal A; Beg AA; Chellappan SP; Haura EB; Cheng JQ
Oncogene; 2024 Apr; 43(16):1231. PubMed ID: 38443683
[No Abstract] [Full Text] [Related]
35. Expression of concern: Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression.
Wang F; Zhang W; Wu T; Chu H
Open Biol; 2020 Jun; 10(6):200152. PubMed ID: 32516547
[No Abstract] [Full Text] [Related]
36. Retraction 'Reduced interleukin-38 in non-small cell lung cancer is associated with tumour progression'.
Wang F; Zhang W; Wu T; Chu H
Open Biol; 2020 Jul; 10(7):200204. PubMed ID: 32692958
[No Abstract] [Full Text] [Related]
37. Checkpoint inhibitors are a basic science-based, transformative new treatment for lung cancer.
Miller AR
Respirology; 2023 Feb; 28(2):101-106. PubMed ID: 36535890
[No Abstract] [Full Text] [Related]
38. Blockade of the protease ADAM17 ameliorates experimental pancreatitis.
Saad MI; Weng T; Lundy J; Gearing LJ; West AC; Harpur CM; Alanazi M; Hodges C; Croagh D; Kumar B; Sagi I; Rose-John S; Jenkins BJ
Proc Natl Acad Sci U S A; 2022 Oct; 119(42):e2213744119. PubMed ID: 36215509
[TBL] [Abstract][Full Text] [Related]
39. Lymphoma-Associated Biomarkers Are Increased in Current Smokers in Twin Pairs Discordant for Smoking.
Wang J; Conti DV; Epeldegui M; Ollikainen M; Tyndale RF; Hwang AE; Magpantay L; Mack TM; Martinez-Maza O; Kaprio J; Cozen W
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771561
[TBL] [Abstract][Full Text] [Related]
40. ADAM17: An Emerging Therapeutic Target for Lung Cancer.
Saad MI; Rose-John S; Jenkins BJ
Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31438559
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
